Status
Conditions
About
This study will collect real-world safety and efficacy data from Japanese relapse/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) participants treated with venetoclax.
Enrollment
Sex
Volunteers
Inclusion criteria
-Prescribed and treated with venetoclax
Exclusion criteria
None
4 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal